Pharma Pulse 3/31/25: The Impact of Funding Cuts on Medical Research, Training Pharmacy Technicians as Community Health Workers & more

The Impact of Funding Cuts on Medical Research

In a recent video interview with Applied Clinical Trials, Craig Lipset, co-chair, Decentralized Trials & Research Alliance, discussed the impact of recent regulatory decisions on clinical research. Funding cuts by the NIH will affect intramural research and shared infrastructure. Additionally, the politicization of diversity initiatives will affect the enforcement of action plans. Lipset also highlighted the industry’s response to these actions and what it can expect moving forward.

APhA 2025: Training Pharmacy Technicians as Community Health Workers

In an interview with Pharmacy Times®, Nancy Lyons, BSPharm, MBA, CDCES, vice president and chief pharmacy officer from Health Mart, discussed the role of pharmacy technicians as community health workers, highlighting her presentation at the American Pharmacists Association (APhA) Annual Meeting & Exposition.

Lyons shared that pharmacy technicians are being trained as community health workers (CHW) to enhance patient care beyond traditional pharmacy roles. By identifying social determinants of health and forming community connections, these technicians can help patients overcome barriers to health care access. She highlighted that the training provides career development opportunities for technicians and supports pharmacists in delivering more comprehensive care. Lyons emphasized that this innovative approach benefits patients, pharmacy teams, and the broader health care ecosystem by creating more engaged and resourceful health care professionals.

Pharma Could Be Next Affected by Tariffs: Lombard Odier

Lombard Odier EMEA CIO Nannette Hechler-Fayd'herbe discusses the market impact of upcoming US tariffs on the auto sector. Speaking on Bloomberg Television, she says the impact of tariffs is "not fully priced by markets." Hechler-Fayd'herbe also adds that the pharmaceuticals sector may be the next to be affected by tariffs coming from President Donald Trump's administration.

Novotech Report Reveals Growth in siRNA Research: Over 150 Industry-Sponsored Clinical Trials Conducted from 2020 to 2024

Novotech has released its newest preclinical report exploring the evolving landscape of small interfering RNA (siRNA) therapeutics. The report provides insights for biotech and pharmaceutical companies leveraging RNA-based precision medicine to develop next-generation treatments for oncology, metabolic disorders, and rare genetic diseases.

Pharmaceutical Executive on LinkedIn

The editors of Pharmaceutical Executive® invite you to participate in the State of the Industry Survey, designed for leaders and decision-makers in the pharmaceutical and biotech industries.

This is an opportunity to share your perspective on the challenges and trends shaping the industry, from workforce issues and regulatory shifts to innovation strategies. Your input, along with insights from other executives and experts, will help create a comprehensive view of where the industry is headed.

Take the survey today!https://lnkd.in/eFKmeV9y

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs